Artificial Intelligence (AI) in Genomics: Global Market

Report Code: HLC281A

Publish Date: Jun 2022

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for AI in genomics reached $498.6 million in 2021 and should reach more than $4.8 billion in 2027, with a compound annual growth rate (CAGR) of 47.3% during the forecast period of 2021-2027.

Report Includes

  • 23 data tables and 19 additional tables
  • An overview of the global market for artificial intelligence (AI) in genomics applications
  • Analyses of the global market trends, with revenue data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential for the AI genomics industry with an emphasis on new products and technologies, and areas of focus to forecast this market into various segments and sub-segments
  • Evaluation and forecast the global AI genomics market size, and corresponding market share analysis by technology, offerings, application, and geographic region
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI in genomics over the forecast period (2021 to 2027)
  • In-depth information on major technology issues and challenges, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of AI applications in the genomics industry
  • Review of recent industry trends, R&D activities, competitive landscape featuring key market participants, and COVID-19 implications within the AI genomics market ecosystem
  • Company profiles of major players within the industry, including BenevolentAI, Data4Cure Inc., Deep Genomics, IBM Corp., and Microsoft Corp.

Report Scope

This report highlights the current and future market potential for AI genomics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 as well as key market players. BCC Research analyzes each technology in detail, determines major players and current market
status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents, and factors affecting the industry from a global perspective are examined.

Key AI in genomics technologies and products are analyzed to determine present and future market status, and growth is forecast from 2022 to 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market driving forces are also provided.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $498.6 million
Market size forecast $4.8 billion
Growth rate CAGR of 47.3% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Offering, technology, application, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Investment In Ai Health Sector
  • Increasing Strategic Moves By Market Players And Governments
  • Increasing Incidences Of Chronic Disease
  • Demand For Personalized Medicine
  • Increasing Research And Development Budget
Companies studied
BENEVOLENTAIDATA4CURE INC.
DEEP GENOMICSDNANEXUS INC.
FDNA INC.GENOOX
IBM CORP.LIFEBIT
MICROSOFT CORP.NVIDIA CORP.
SOPHIA GENETICS
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Artificial Intelligence (AI) in Genomics: Global Market104Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Overview4Free
Chapter- 4: Impact of the COVID-19 Pandemic3Free
Chapter- 5: Market Dynamics9Free
Chapter- 6: Market Breakdown by Offering5Free
Chapter- 7: Market Breakdown by Technology5Free
Chapter- 8: AI in Genomics by Application9Free
Chapter- 9: Market Breakdown by Region34Free
Chapter- 10: Regulations and Finance4Free
Chapter- 11: Patent Review3Free
Chapter- 12: Competitive Landscape5Free
Chapter- 13: Company Profiles14Free

Related Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - Austin Samuel | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Global Markets for Artificial Intelligence in Drug Discovery

Published - Sep 2023 | Publisher - BCC Publishing | Code - HLC290A

The global market for artificial intelligence (AI) in drug discovery is estimated to increase from $1.6 billion in 2023 to $5.7 billion by 2028, at a compound annual growth rate (CAGR) of 29.6% from 2023 through 2028.

Global Markets for Machine Learning in the Life Sciences

Published - Oct 2022 | Publisher - BCC Publishing | Code - HLC284A

The global market for machine learning in the life sciences is estimated to increase from $3.2 billion in 2022 to reach $20.7 billion by 2027, at a compound annual growth rate (CAGR) of 45.5% from 2022 through 2027.

Recent Reports

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - HLC071E

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Top Trending Reports

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Artificial Intelligence (AI) in Genomics: Global Market
Customize Report